protein hydrolysate - Profile
✉ Email this page to a colleague
What are the generic drug sources for protein hydrolysate and what is the scope of patent protection?
Protein hydrolysate
is the generic ingredient in two branded drugs marketed by Abbvie and B Braun, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for protein hydrolysate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 2 |
| NDAs: | 2 |
US Patents and Regulatory Information for protein hydrolysate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | AMINOSOL 5% | protein hydrolysate | INJECTABLE;INJECTION | 005932-012 | Jan 31, 1985 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| B Braun | HYPROTIGEN 5% | protein hydrolysate | INJECTABLE;INJECTION | 006170-003 | Jan 10, 1984 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
